Funding
Funding not disclosed
Founders
Product
Problem
Healthcare providers and wellness retailers lack clinically validated, protocol-driven longevity supplements that can be reliably integrated into professional distribution channels, limiting their ability to offer evidence-based anti‑aging solutions to patients.
Solution
TWIG Therapeutics addresses this gap by developing proprietary, protocol‑based senolytic products designed for B2B distribution. Their flagship offering, TWIG Senolytics, is a structured five‑day monthly regimen that supports cellular renewal pathways. Each product is pre‑packaged in 15 sachets containing three capsules of fisetin, quercetin, and piper longum, providing a complete three‑month program. Manufacturing is performed in California under quality‑controlled conditions, and the product is positioned exclusively for qualified distributors, clinics, pharmacies, and licensed market operators. By offering a ready‑to‑sell, clinically oriented protocol, TWIG enables partners to expand their premium wellness portfolios without developing formulations in‑house.
Target Audience
Primary customers are national and regional distributors, clinics, pharmacies, and healthcare organizations seeking to add a validated longevity protocol to their product lines, as well as licensees pursuing exclusive or semi‑exclusive territory development.
Features
- Five‑day monthly senolytic protocol delivering a standardized anti‑aging regimen
- Pre‑packaged 15‑sachet boxes, each containing three capsules of fisetin, quercetin, and piper longum
- Three‑month supply per box, simplifying inventory and patient adherence
- Manufacturing in California with GMP‑aligned quality controls
- Designed exclusively for professional distribution through qualified partners, clinics, pharmacies, and licensed operators
- Supports integration into premium wellness, preventive health, and medical tourism offerings